(Q24634801)

English

Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit